pharmaphorum

AUGUST 18, 2022

The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”

FDA 52

FDA Insurance Patients Medical 52

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Side effects 52

Side effects Patients Medical Medicine 52

Healthcare Success

JULY 11, 2022

In 2018, Europe launched new privacy and security regulations to protect European citizens in Europe and on any website they browse—regardless of where the site is hosted. As a result of these new, stricter data standards, it became illegal to use the UA platform in Europe, largely due to its reliance on third-party cookie data.

Healthcare 95

Healthcare Healthcare Patients Marketing 95

pharmaphorum

NOVEMBER 16, 2022

However, with a price tag of €1.58 However, a recently released report from the organisation could blow the price tag of Zolgensma out of the water. When even high-income regions like Europe are refusing to meet the price tag of certain gene therapies, it is likely the debate on pricing is set to continue in the long-term.

Medicine 128

Medicine Marketing Healthcare Healthcare 128

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. The post Roctavian okay sets up another gene therapy test for Europe appeared first on. million spread over five years.

FDA 109

FDA Marketing Competition Patients 109

Clarivate

JULY 27, 2023

We studied patent landscape of XG(S)-PON technology by performing manual analysis of related patents to identify standard relevant patent families and tagging them into one or more technical categories identified based on ITU-T XG(S)-PON standard. We also studied patent distribution in Mainland China, Europe, or the U.S. [1]

Networking 52

Networking Distribution Media Management 52

Pharmaceutical Technology

JANUARY 27, 2023

cases per million in Europe. Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth. The disorder has a reported annual incidence between 1.5

Patients 52

Patients Pharmaceutical Manufacturing Healthcare Provider 52

European Pharmaceutical Review

DECEMBER 27, 2023

Important reassurance about CAR T-cell therapy came with the real-world data that emerged from both large single centres and various consortiums, which included data from both adult and paediatric patients in Israel and Europe. This is in addition to its considerable price tag.

Manufacturing 84

Manufacturing Food and Drug Administration Patients Pharma 84

Cadensee

JANUARY 1, 2022

It's already tagged by clinicians with the diagnosis, so you have to do the machine learning and the engineering side. We are working obviously in Europe, which is Israel, UK with NHS, France, Switzerland. Most of the AI companies that you know are doing imaging AI and basically buying data, digital data from hospitals.

Marketing 52

Marketing Physicians Medical Healthcare 52